Prospect Capital Corporation 6.25% Notes due 2028

(PBY) Trade

By |

Profile

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.

Contact Information

Website: www.precisionbiosciences.com
Email: InvestorRelations@prospectstreet.com
Main Phone: +1 919 314-5512
Address: 302 East Pettigrew Street
Address 2: Dibrell Building, Suite A-100
State: NC
City / Town: Durham
Country: USA
Postal Code: 27701

Issuer Information

Exchange: NYE
CEO: Matthew Kane
Employees: 184
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.

Contact Information

Website: www.precisionbiosciences.com
Email: InvestorRelations@prospectstreet.com
Main Phone: +1 919 314-5512
Address: 302 East Pettigrew Street
Address 2: Dibrell Building, Suite A-100
State: NC
City / Town: Durham
Country: USA
Postal Code: 27701

Issuer Information

Exchange: NYE
CEO: Matthew Kane
Employees: 184
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 25.59 $ 0.0754 (0.30%)
Last Price 25.59 Change $ 0.0754 Change % 0.30 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 25.55 High 25.65 Low 25.55 Prev Close 25.51
Last Trade Volume 946 52 Wk Hi 26.69 52 Wk Low 21.90
Market Cap 1.3 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 50,787,317.00 EPS (TTM) -3.25 PE Ratio N/A Exchange NYSE
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Carl C. Icahn 1,000
Carl C. Icahn 1,000
Mario J. Gabelli 1,000
Michael R. Odell 1,000
Jane Scaccetti 1,000
Jane Scaccetti 1,000
Jane Scaccetti 1,000
Jane Scaccetti 1,000
Scott Webb 1,000
Raymond L. Arthur 1,000
Last 10 Sell Shares
James A. Mitarotonda 1,000
James A. Mitarotonda 1,000
James A. Mitarotonda 1,000
James A. Mitarotonda 1,000
Joseph A. Cirelli 1,000
Joseph A. Cirelli 1,000
Joseph A. Cirelli 1,000
Nick White 1,000
Troy E. Fee 1,000
Brian D. Zuckerman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 15 15 15 15
Mean Target Price Estimate 15 15 15 15
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 10/26/15 10/26/15 10/26/15 10/26/15
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 1 2
Moderate Buy 0 0 0 0
Hold 3 3 2 2
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 1
Mean Rec. 3.8 3.8 3.4 2.6